Related Experiment Videos
Second-look laparotomy in ovarian cancer
1Department of Obstetrics and Gynecology, Medical University of South Carolina, Charleston 29425.
Gynecologic Oncology
|December 1, 1994
Summary
Second-look laparotomy in ovarian cancer shows minimal survival benefit, especially in early stages. Its role is primarily for evaluating treatment effectiveness in clinical trials.
Area of Science:
- Gynecologic Oncology
- Surgical Oncology
Background:
- Second-look laparotomy is a standard procedure for ovarian cancer patients.
- Its impact on survival remains controversial and lacks robust evidence.
Purpose of the Study:
- To evaluate the clinical utility and survival impact of second-look laparotomy in ovarian cancer management.
- To assess the benefit of this procedure in early-stage versus advanced-stage disease.
Main Methods:
- Review of existing data and clinical evidence regarding second-look laparotomy outcomes.
- Analysis of survival rates and recurrence patterns in patients undergoing the procedure.
Main Results:
- Limited survival benefit observed, particularly in early-stage ovarian cancer with optimal staging and therapy.
- Even with negative findings, recurrence rates remain high (50%) in advanced disease.
- Potential benefit as a secondary debulking procedure is limited to a small patient subset (<10%).
Conclusions:
- Second-look laparotomy offers minimal survival advantage in most ovarian cancer patients.
- It is justified in clinical trials as a gold standard to assess treatment efficacy.
- Further research is needed to define its role in specific patient subgroups.